Photocatalytic degradation of ibuprofen in water using TiO₂ and ZnO under artificial UV and solar irradiation

The degradation of anti-inflammatory and antipyretic drug (Ibuprofen; IBP) has been described in this study by using photocatalytic-based advanced oxidation processes. The catalysts (TiO₂ and ZnO) were activated by irradiation of artificial UV lamp and solar rays for the generation of highly oxidizing species which resulted in the degradation of IBP to intermediates and finally to carbon dioxide and water. In solar reactor, quartz and borosilicate tubes were installed for absorption of required ultraviolet rays and curved chrome plates were used to reflect and concentrate rays on the tubes containing feed mixture. The liquid chromatography, Total organic carbon (TOC), and Chemical oxygen demand (COD) tests were employed to determine the degradation rates and demineralization of solution samples. At catalyst dosing of 1–1.5 g/L, TiO₂-based experiments showed high degradation rate under acidic conditions. Similarly, for ZnO catalyst, 1 g/L dozing rate was found to be effective under neutral conditions (pH = 7.0). UV lamp-based photocatalysis had higher degradation rate as compared to that of solar reactor. Moreover, better absorption of solar rays by quartz tubes resulted in higher degradation than that in borosilicate tubes. For UV lamp photocatalysis, the TOC and COD reduction was higher. With improved catalyst doping and better solar reactor design, solar-based IBP degradation could be more promising than UV-based catalysis.